It is a once-weekly injectable medication that combines the effects of two naturally occurring hormones, GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide), to help regulate blood sugar levels and support weight loss
Any consideration of combined use should only occur under specialist supervision (endocrinologist or metabolic physician) within a formal clinical trial or with robust multidisciplinary oversight
Appetite Regulation: Experience reduced cravings and more controlled food intake
A frozen and thawed vial should be discarded entirely
Early and precise interventions, using a comprehensive systems-biology approach, are vital for improving overall health outcomes
But, since the mapping of the human genome is relatively new and we would have no a priori way of knowing which genes are associated with which outcomes, this GWAS discovery strategy is hugely valuable